Research & Development
Hepatitis: Page 2
Roche launches adenovirus PCR test in Europe
Transplant patients are immunocompromised and at risk for developing infections, including from adenoviruses. Adenoviruses can lead to a range of conditions -- such as conjunctivitis, gastroenteritis, hepatitis, and pneumonia -- that cause complications and organ rejection in transplant patients.
January 14, 2020
ASCP tackles hepatitis C, stool pathogens, and more in new test guidelines
The society shared the guidelines ahead of its annual meeting, scheduled for September 11-13 in Phoenix. The recommendations are part of the Choosing Wisely program, an initiative of the American Board of Internal Medicine (ABIM) Foundation designed to ensure evidence-based medicine and foster dialogue about tests and treatments. The ASCP is one of 70 medical specialty associations that have published recommendations about tests and treatments as part of the initiative.
September 9, 2019
Intriguing results for inflammation blood test | Dollars and sense on tests | USPSTF's new stance on hepatitis C screening
Dear LabPulse Member,
September 2, 2019
USPSTF proposes big expansion of hepatitis C screening
The USPSTF gave a B recommendation stating that all adults between the ages of 18 and 79 should undergo screening. Furthermore, the task force advised that screening should be considered for people younger than 18 and older than 79 who are at high risk of infection. The B recommendation means there is high certainty that the net benefit of hepatitis C screening is moderate.
August 27, 2019
USPSTF renews support for routine hepatitis B screening
The statement on hepatitis B gives a grade A recommendation -- meaning the task force has high confidence in the evidence -- for routine screening with the hepatitis B surface antigen (HBsAg) test for all pregnant women. Ideally, testing should be performed in the first trimester, but it should at least be done in an early prenatal visit, according to Stanford University health policy expert Dr. Douglas Owens and colleagues on the task force (JAMA, July 23/30, 2019, Vol. 322:4, pp. 349-354).
July 22, 2019
Abbott's Alinity s gets FDA green light for hepatitis C
The BLA covers the use of hepatitis C virus-encoded antigens for screening individual donors, including volunteer donors, of whole blood and blood components and living donors for the presence of the hepatitis C virus.
July 11, 2019
Page 2 of 2